IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma

por Myers, Amy L., Lin, Lin, Nancarrow, Derek J., Wang, Zhuwen, Ferrer-Torres, Daysha, Thomas, Dafydd G., Orringer, Mark B., Lin, Jules, Reddy, Rishindra M., Beer, David G., Chang, Andrew C.
Publicado 2015

Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma

por Lin, Jules, Myers, Amy L., Wang, Zhuwen, Nancarrow, Derek J., Ferrer-Torres, Daysha, Handlogten, Amy, Leverenz, Kimmy, Bao, Julia, Thomas, Dafydd G., Wang, Thomas D., Orringer, Mark B., Reddy, Rishindra M., Chang, Andrew C., Beer, David G., Lin, Lin
Publicado 2015

Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context

por Kerk, Samuel A, Lin, Lin, Myers, Amy L, Sutton, Damien J, Andren, Anthony, Sajjakulnukit, Peter, Zhang, Li, Zhang, Yaqing, Jiménez, Jennifer A, Nelson, Barbara S, Chen, Brandon, Robinson, Anthony, Thurston, Galloway, Kemp, Samantha B, Steele, Nina G, Hoffman, Megan T, Wen, Hui-Ju, Long, Daniel, Ackenhusen, Sarah E, Ramos, Johanna, Gao, Xiaohua, Nwosu, Zeribe C, Galban, Stefanie, Halbrook, Christopher J, Lombard, David B, Piwnica-Worms, David R, Ying, Haoqiang, Pasca di Magliano, Marina, Crawford, Howard C, Shah, Yatrik M, Lyssiotis, Costas A
Publicado 2022